Cancer Trials Support Unit

The National Cancer Institute awarded this Master IDIQ on August 1, 2022 to provide operational, administrative, regulatory, IT, and logistical support services for multi-institutional cancer clinical trials conducted nationally and internationally. Ordering authority expires July 31, 2027, leaving approximately 13 months of placement window. The vehicle carries a $548 million shared ceiling and a 10-year ordering period through July 31, 2032.

All six task orders were awarded on the vehicle's establishment date and represent the complete order history; no new awards have been issued in the three years since inception, and no additional orders are anticipated before the ordering deadline. Task orders obligate $93.7 million against $242.3 million in combined potential value, representing 39% utilization. The portfolio covers six functional task areas: project kick-off meetings, core support services and enterprise systems, awareness and education, site study setup, centralized protocol writing support, and electronic patient-reported outcomes management.

Westat, Inc. dominates the vehicle, holding three of six awards with $230.6 million in combined potential value—approximately 95% of the vehicle's total obligation and ordering capacity. Three smaller primes hold the remaining orders: EDJ Associates, Inc. ($6.1 million potential), Technical Resources International, Inc. ($5.6 million potential), and PPD Development LP ($2 thousand potential). All six orders fund the National Cancer Institute exclusively.

Two-thirds of awards carry no set-aside designation; two-thirds of the remaining orders are small-business-set-aside. All task orders structure work as Cost Plus Fixed Fee except one Cost Sharing order. Ceiling values range from $2,245 to $214.4 million; most orders extend through July 31, 2027 or July 31, 2032. The largest order to Westat covers core support services and enterprise systems ($214.4 million ceiling, $76.6 million obligated through 2032) and represents the operational anchor for the vehicle. A second Westat order for site study setup carries a $12.3 million ceiling (Ultimate Completion Date July 31, 2027).

With 13 months of placement window remaining and no recent ordering activity, the window for new prime awards or task-order origination under this vehicle is closing. Existing incumbents hold the contracted scope, and competitive opportunities are limited to downstream subcontracting or task order modifications within the established six-firm structure.

The purpose of this contract is to provide broad-based, centralized and fully integrated operational, administrative, regulatory, information technology (IT), and logistical support services to support the participation of multiple sites both nationally and internationally in multi-institutional cancer trials led by NCI-supported clinical trial organizations.